B细胞OX40L支持滤泡辅助性T细胞发育并促进SLE发病
该研究利用条件性基因敲除小鼠系统,探讨B细胞和T细胞上OX40L在系统性自身免疫中的功能。结果显示B细胞OX40L支持二次体液免疫应答和抗体亲和力成熟,并促进脾脏滤泡辅助性T细胞生成;在两种SLE模型中,B细胞OX40L缺失可改善自身免疫表型并伴随滤泡辅助性T细胞数量下降。
要点
- B细胞OX40L支持二次体液免疫应答及抗体亲和力成熟。
- B细胞OX40L缺失阻碍脾脏滤泡辅助性T细胞生成。
- 两种SLE模型中B细胞OX40L缺失改善自身免疫表型。
核心结论
- B细胞OX40L通过支持滤泡辅助性T细胞发育促进SLE发病,是SLE的潜在治疗靶点。
研究设计与样本
- 使用条件性基因敲除小鼠系统研究OX40L在B和T淋巴细胞中对系统性自身免疫的功能。
主要发现
- 生理状态下B细胞和T细胞OX40L均参与体液免疫应答,但B细胞OX40L支持二次体液应答和抗体亲和力成熟。
- B细胞OX40L缺失阻碍脾脏滤泡辅助性T细胞生成。
- 在自发性同源基因模型和H2-IAbm12移植物抗宿主诱导的SLE模型中,B细胞OX40L缺失改善自身免疫表型并伴随滤泡辅助性T细胞数量下降。
- 在上述模型中,种系敲除与B细胞敲除表型无显著差异。
临床怎么用
- OX40L blockade可能作为SLE治疗策略,尤其靶向B细胞OX40L。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: TNFSF4 (encodes OX40L) is a susceptibility locus for systemic lupus erythematosus (SLE). Risk alleles increase TNFSF4 expression in cell lines, but the mechanism linking this effect to disease is unclear, and the OX40L-expressing cell types mediating the risk are not clearly established. Blockade of OX40L has been demonstrated to reduce disease severity in several models of autoimmunity, but not in SLE. We sought to investigate its potential therapeutic role in lupus. METHODS: We used a conditional knockout mouse system to investigate the function of OX40L on B and T lymphocytes in systemic autoimmunity. RESULTS: Physiologically, OX40L on both B and T cells contributed to the humoral immune response, but B cell OX40L supported the secondary humoral response and antibody affinity maturation. Our data also indicated that loss of B cell OX40L impeded the generation of splenic T follicular helper cells. We further show that in two models of SLE-a spontaneous congenic model and the H2-IAbm12 graft-versus-host-induced model-loss of B cell OX40L ameliorates the autoimmune phenotype. This improvement was, in each case, accompanied by a decline in T follicular helper cell numbers. Importantly, the germline knockout did not exhibit a markedly different phenotype from the B cell knockout in these models. CONCLUSIONS: These findings contribute to a model in which genetically determined increased OX40L expression promotes human SLE by several mechanisms, contingent on its cellular expression. The improvement in pathology in two models of systemic autoimmunity indicates that OX40L is an excellent therapeutic target in SLE.
引用
- Cortini A, Ellinghaus U, Malik TH, et al. B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis. Ann Rheum Dis. 2017. PMID: 28818832. doi:10.1136/annrheumdis-2017-211499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。